EGX breaks its green streak by closing Wednesday trading on a mixed note
Cairo – May 28, 2025: The Egyptian Exchange (EGX) broke its green streak by closing today's session with a mixed performance.
Benchmark index EGX 30 was up by 0.3 percent during Wednesday's session, reaching 32,493.89 points.
The Shariah index slipped by 0.07 percent to end the session with 3,342.37 points.
EGX 70 dropped by 0.46 percent to hit 9,471.42 points, followed by EGX 100 declining by 0.37 percent to close the session with 12,914.67 points.
Wednesday trading reported over 1.322 billion shares exchanged with a turnover of LE 4.944 billion.
Market capitalization was recorded at LE 2.2859 trillion.
Trading on securities saw Egyptian and Arab investors as net sellers with LE 33.2 million and LE 9.1 million, respectively. Foreign investors were net buyers with LE 42.3 million.
The top gains of the session were by October Pharma which climbed by 16.35 percent, Misr National Steel – Ataqa by 7.41 percent, and The Egyptian Modern Education Systems by 7.09 percent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Egypt Today
a day ago
- Egypt Today
Egypt's pharmaceutical sector gearing up to inject $80M to bolster local production
Cairo – May 29, 2025: Egypt's pharmaceutical industry is preparing to invest approximately LE 4 billion ($80 million) this year to boost domestic production, with 20 new manufacturing lines in the pipeline. The initiative aligns with a national strategy to cut reliance on imported medicines and reinforce the country's local pharmaceutical capabilities. The expansion will bring the total number of operational pharmaceutical production lines across Egypt to 810, according to Gamal El Leithy, Chairman of the Chamber of Pharmaceutical Industry at the Federation of Egyptian Industries, speaking to Asharq Business. This increase is expected to play a key role in replacing approximately $3 billion worth of annual pharmaceutical imports with locally produced alternatives. Local manufacturers currently supply around 91 percent of the country's pharmaceutical needs. The sector has seen robust growth, with total medicine sales surging by over 40 percent last year to reach LE 307 billion. Pharmaceutical sales in January and February alone climbed to LE 62 billion, up from about LE 40 billion in the same period the previous year. The growth was largely driven by an uptick in production volume, particularly in packaged medications, according to previous comments by Ali El-Ghamrawy, head of the Egyptian Drug Authority. Looking ahead, Egypt is aiming to localize the manufacturing of high-priority and specialized medicines. El Leithy said key targets include cancer treatments, immunodeficiency drugs, medical imaging dyes, and infant formula. These efforts form part of a strategic national plan to raise pharmaceutical exports to $3 billion by 2030. Recent export data suggests that momentum is already building. In the first quarter of 2025, exports of pharmaceutical and medical products rose 25 percent year-on-year, reaching $205 million, according to figures from the General Organization for Export and Import Control.
Egypt Today
2 days ago
- Egypt Today
EGX breaks its green streak by closing Wednesday trading on a mixed note
Cairo – May 28, 2025: The Egyptian Exchange (EGX) broke its green streak by closing today's session with a mixed performance. Benchmark index EGX 30 was up by 0.3 percent during Wednesday's session, reaching 32,493.89 points. The Shariah index slipped by 0.07 percent to end the session with 3,342.37 points. EGX 70 dropped by 0.46 percent to hit 9,471.42 points, followed by EGX 100 declining by 0.37 percent to close the session with 12,914.67 points. Wednesday trading reported over 1.322 billion shares exchanged with a turnover of LE 4.944 billion. Market capitalization was recorded at LE 2.2859 trillion. Trading on securities saw Egyptian and Arab investors as net sellers with LE 33.2 million and LE 9.1 million, respectively. Foreign investors were net buyers with LE 42.3 million. The top gains of the session were by October Pharma which climbed by 16.35 percent, Misr National Steel – Ataqa by 7.41 percent, and The Egyptian Modern Education Systems by 7.09 percent.
Egypt Today
3 days ago
- Egypt Today
U Consumer Finance S.A.E., Known Under the Trademark of 'Valu', Announces its Intention to Float on The Egyptian Exchange
U Consumer Finance S.A.E. ('Valu'), the leading universal financial technology powerhouse in Egypt, announced today its intention to proceed with the trading of its shares on the Egyptian Exchange (the 'EGX'), following the completion of an in-kind dividend distribution* by EFG Holding S.A.E. ('EFG Holding') (the 'Dividend Distribution'). Valu was listed on the EGX on 21 May 2025 (the 'Listing,' and together with the Dividend Distribution, the 'Transaction'). Valu's shares will be admitted to trading on the EGX following registration with the Egyptian Financial Regulatory Authority (the 'FRA'), the completion of the Dividend Distribution and the ratification of the trading disclosure report by the FRA**. The Dividend Distribution was approved by the Ordinary General Assembly meeting of the shareholders of EFG Holding on 24 May 2025 (the 'OGM'). The OGM approved the utilization of EGP 335,322,346 out of the distributable retained earnings of EFG Holding, which figure is based on the financial statements of EFG Holding for the financial year ending on 31 December 2024, for the purposes of an in-kind dividend distribution (in lieu of a cash dividend distribution) to the shareholders of EFG Holding, in the form of shares in the share capital of Valu, which shares represent 20.488% of the share capital of Valu. The Dividend Distribution is based on Valu's book value according to the consolidated financial statements for the financial year ending on 31 December 2024. The ratio of the number of Valu shares that will be allocated to the shareholders of EFG Holding is 1 Valu share per 3.3273 EFG Holding shares (with fractional shares allocated to minority shareholders). As announced earlier today, EFG Holding has determined that the record date is set on 12 June 2025, for the owners of shares of EFG Holding and the purchasers of shares of EFG Holding, as of the end of the trading session held on the Thursday 12 June 2025, which accordingly will become direct shareholders in Valu, after completing the necessary procedures. The commencement of trading on the Valu shares on the EGX is expected to take place during the week commencing on 22 June 2025, subject to receipt of the relevant regulatory approvals. Valu and EFG Holding engaged EFG Hermes Promoting and Underwriting S.A.E. to act as sole financial advisor in connection with the Transaction, and Zulficar & Partners to act as legal counsel. EFG Holding also engaged Gibson, Dunn & Crutcher LLP to act as legal counsel to EFG Holding in connection with the international aspects of the Transaction. Commenting on the Listing, Walid Hassouna, Valu's Chief Executive Officer, said: "This listing marks a significant milestone in Valu's journey, and is a testament to the disruptive and positive impact we have made in the market as one of the leading fintech players in the MENA region and Egypt's leading fintech platform. With the full backing of our parent EFG Holding, we're unlocking new value for our customers and shareholders, and accelerating our mission to democratize access to finance in the region.' *An in-kind dividend is a non-cash payout of assets to shareholders, often used for distributing securities, property, or other assets instead of cash. **Please note that the trading disclosure report has not been ratified by the FRA yet.
